A new study has revealed that tough liver cancer (Hepatocellular Carcinoma) can now be tackled by adoptive T-cell therapy. This new therapeutic approach in the treatment of HCC could be very important as without treatment the 5 year survival rate is just 5%. Globally, HCC accounts for 746,000 deaths, and in the UK alone is responsible for over 4,000 deaths per year. Glypican-3 (GPC3) is a tumour associated antigen expressed in up to 70% of HCC but not ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment